Arkansas § 20-77-138 Medications approved by United States Food and Drug Administration for tobacco cessation coverage

Arkansas Statutes

§ 20-77-138 — Medications approved by United States Food and Drug Administration for tobacco cessation coverage

Arkansas § 20-77-138

Title20

This text of Arkansas § 20-77-138 (Medications approved by United States Food and Drug Administration for tobacco cessation coverage) is published on Counsel Stack Legal Research, covering Arkansas primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Ark. Code Ann. § 20-77-138 (2026).

Text

(a)The Department of Human Services shall ensure that the Arkansas Medicaid Program covers medications approved by the United States Food and Drug Administration for tobacco cessation, including without limitation:

(1)Nicotine replacement therapy patches;

(2)Nicotine replacement therapy gum;

(3)Nicotine replacement therapy lozenges;

(4)Nicotine replacement therapy nasal spray;

(5)Nicotine replacement therapy inhalers;

(6)Bupropion; and (7) Varenicline.

(b)Prior authorization shall not be required for coverage of medications described in subsection (a) of this section.

Free access — add to your briefcase to read the full text and ask questions with AI

(a) The Department of Human Services shall ensure that the Arkansas Medicaid Program covers medications approved by the United States Food and Drug Administration for tobacco cessation, including without limitation: (1) Nicotine replacement therapy patches; (2) Nicotine replacement therapy gum; (3) Nicotine replacement therapy lozenges; (4) Nicotine replacement therapy nasal spray; (5) Nicotine replacement therapy inhalers; (6) Bupropion; and (7) Varenicline. (b) Prior authorization shall not be required for coverage of medications described in subsection (a) of this section.